BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 25433820)

  • 1. A systematic review and meta-analysis of adjuvant chemotherapy after neoadjuvant treatment and surgery for rectal cancer.
    Petrelli F; Coinu A; Lonati V; Barni S
    Int J Colorectal Dis; 2015 Apr; 30(4):447-57. PubMed ID: 25433820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-course preoperative radiotherapy with immediate surgery versus long-course chemoradiation with delayed surgery in the treatment of rectal cancer: a systematic review and meta-analysis.
    Zhou ZR; Liu SX; Zhang TS; Chen LX; Xia J; Hu ZD; Li B
    Surg Oncol; 2014 Dec; 23(4):211-21. PubMed ID: 25466851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials.
    Zhao L; Liu R; Zhang Z; Li T; Li F; Liu H; Li G
    Colorectal Dis; 2016 Aug; 18(8):763-72. PubMed ID: 27169752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological outcomes of local excision compared with radical surgery after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis.
    Shaikh I; Askari A; Ourû S; Warusavitarne J; Athanasiou T; Faiz O
    Int J Colorectal Dis; 2015 Jan; 30(1):19-29. PubMed ID: 25367179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is adjuvant chemotherapy necessary for locally advanced rectal cancer patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery? A systematic review and meta-analysis.
    Ma B; Ren Y; Chen Y; Lian B; Jiang P; Li Y; Shang Y; Meng Q
    Int J Colorectal Dis; 2019 Jan; 34(1):113-121. PubMed ID: 30368569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy after neoadjuvant chemoradiation and curative resection for rectal cancer: is it necessary for all patients?
    Jung KU; Kim HC; Park JO; Park YS; Park HC; Choi DH; Cho YB; Yun SH; Lee WY; Chun HK
    J Surg Oncol; 2015 Mar; 111(4):439-44. PubMed ID: 25488390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor compliance with adjuvant chemotherapy use associated with poorer survival in patients with rectal cancer: An NCDB analysis.
    Xu Z; Mohile SG; Tejani MA; Becerra AZ; Probst CP; Aquina CT; Hensley BJ; Arsalanizadeh R; Noyes K; Monson JR; Fleming FJ
    Cancer; 2017 Jan; 123(1):52-61. PubMed ID: 27560162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is adjuvant chemotherapy necessary for patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery in locally advanced rectal cancer? Long-term analysis of 40 ypCR patients at a single center.
    Zhou J; Qiu H; Lin G; Xiao Y; Wu B; Wu W; Sun X; Lu J; Zhang G; Xu L; Liu Y
    Int J Colorectal Dis; 2016 Jun; 31(6):1163-8. PubMed ID: 27044403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-Adapted Adjuvant Chemotherapy After Concomitant Fluoropyrimidine-Radiotherapy Neoadjuvant Treatment for Patients With Resectable CT3-4 or N+ Rectal Cancer: Five-Year Disease-Free Survival Results of a Single-Center Series.
    Sastre J; Serrano JJ; Fernández C; Ramirez C; Ortega L; García-Paredes B; Corona J; Alfonso R; Córdoba S; Díaz-Rubio E
    Clin Colorectal Cancer; 2016 Jun; 15(2):128-34. PubMed ID: 26385572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of Neoadjuvant Chemotherapy Alone in Locally Advanced Rectal Cancer.
    Jalil O; Claydon L; Arulampalam T
    J Gastrointest Cancer; 2015 Sep; 46(3):219-36. PubMed ID: 26133151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of postoperative adjuvant chemotherapy in locally advanced rectal cancer patients with ypT1-4N0 after neo-adjuvant chemoradiotherapy].
    You KY; Peng HH; Gao YH; Chen L; Zhou GQ; Chang H; Du XJ; Xiao L; Zeng ZF; Wen BX; Liu MZ
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):708-13. PubMed ID: 24332061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant dose-dense chemotherapy for locally advanced breast cancer: a meta-analysis of published studies.
    Petrelli F; Coinu A; Lonati V; Cabiddu M; Ghilardi M; Borgonovo K; Barni S
    Anticancer Drugs; 2016 Aug; 27(7):702-8. PubMed ID: 27058707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
    Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
    Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of adjuvant chemotherapy on survival and recurrence after curative rectal cancer surgery in patients who are histologically node negative after neoadjuvant chemoradiotherapy.
    Baird DLH; Denost Q; Simillis C; Pellino G; Rasheed S; Kontovounisios C; Tekkis PP; Rullier E
    Colorectal Dis; 2017 Nov; 19(11):980-986. PubMed ID: 28493401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective use of adjuvant chemotherapy for rectal cancer patients with ypN0.
    You KY; Huang R; Ding PR; Qiu B; Zhou GQ; Chang H; Xiao WW; Zeng ZF; Pan ZZ; Gao YH
    Int J Colorectal Dis; 2014 Apr; 29(4):529-38. PubMed ID: 24474499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor location as an indication for adjuvant radiotherapy in pT3N0 rectal cancer after surgery.
    Peng HH; Zhou XH; Zhou TC; Qiu XS; You KY
    Radiat Oncol; 2019 Jan; 14(1):8. PubMed ID: 30651116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of oxaliplatin-based versus fluorouracil-based neoadjuvant chemoradiotherapy and adjuvant chemotherapy for locally advanced rectal cancer.
    Fu XL; Fang Z; Shu LH; Tao GQ; Wang JQ; Rui ZL; Zhang YJ; Tian ZQ
    Oncotarget; 2017 May; 8(21):34340-34351. PubMed ID: 28423720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis : Oxaliplatin in neoadjuvant treatment for rectal cancer.
    De Felice F; Benevento I; Magnante AL; Musio D; Bulzonetti N; Caiazzo R; Tombolini V
    BMC Cancer; 2017 May; 17(1):325. PubMed ID: 28499428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant treatment for resected rectal cancer: impact of standard and intensified postoperative chemotherapy on disease-free survival in patients undergoing preoperative chemoradiation-a propensity score-matched analysis of an observational database.
    Garlipp B; Ptok H; Benedix F; Otto R; Popp F; Ridwelski K; Gastinger I; Benckert C; Lippert H; Bruns C
    Langenbecks Arch Surg; 2016 Dec; 401(8):1179-1190. PubMed ID: 27830368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical, oncological, and functional outcomes of local and radical resection after neoadjuvant chemotherapy or chemoradiotherapy for early- and mid-stage rectal cancer: a systematic review and meta-analysis.
    Tan S; Ou Y; Huang S; Gao Q
    Int J Colorectal Dis; 2023 May; 38(1):132. PubMed ID: 37193915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.